ConductScience.org, home

Paper338162

The immunosuppressive effect of type II mouse interferon preparations on antibody production.

Sonnenfeld G and 2 others. Cell Immunol, 1977. Cited by 171 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The immunosuppressive effect of type II mouse interferon preparations on antibody production. Papers, record 338162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/338162

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The immunosuppressive effect of type II mouse interferon preparations on antibody production.
PubMed
Journal
Cell Immunol
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
171
iCite
Relative citation ratio, by iCite
5.1
iCite
Revised in PubMed
2019-07-20
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sonnenfeld GG
2Mandel ADA D
3Merigan TCT C

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
Immunosuppressive AgentsMajor topic
InterferonsMajor topic
Ammonium Sulfate
Antibody-Producing Cells
BCG Vaccine
Chromatography
Electrophoresis, Polyacrylamide Gel
Hemolytic Plaque Technique
Lymphokines
Tuberculin Test

Source PubMed

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 171 citations.

PMIDTitleJournalYearIn PapersSource
7,022,716The nature of the hepatitis B virus and its mode of replication.Springer Semin Immunopathol1981https://conductscience.org/library/papers/7022716PubMed
6,983,404Modulation of polyclonal B cell differentiation by human leucocyte alpha interferon.Clin Exp Immunol1982https://conductscience.org/library/papers/6983404PubMed
6,716,911Immunostimulation. Clinical and experimental perspectives.Klin Wochenschr1984https://conductscience.org/library/papers/6716911PubMed
6,444,662Interferon as a mediator of human lymphocyte suppression.J Exp Med1980https://conductscience.org/library/papers/6444662PubMed
6,409,809Recombinant mouse interferon-gamma regulation of antibody production.Infect Immun1983https://conductscience.org/library/papers/6409809PubMed
6,407,996Production of human interferon-gamma in serum-free medium.Infect Immun1983https://conductscience.org/library/papers/6407996PubMed
6,407,020Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6407020PubMed
6,317,573Production of gamma interferon in mice immune to Rickettsia tsutsugamushi.Infect Immun1984https://conductscience.org/library/papers/6317573PubMed
6,182,471Immunoregulation by gamma-interferon?Nature1982https://conductscience.org/library/papers/6182471PubMed
6,177,817Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection.J Exp Med1982https://conductscience.org/library/papers/6177817PubMed
6,177,458Natural killer cell function in trisomy-21 (Down's syndrome).Clin Exp Immunol1982https://conductscience.org/library/papers/6177458PubMed
6,176,541Detection of gamma interferon in the sera of patients with Behçet's disease.Infect Immun1982https://conductscience.org/library/papers/6176541PubMed
6,167,846The interferon renaissance: molecular aspects of induction and action.Microbiol Rev1981https://conductscience.org/library/papers/6167846PubMed
6,157,362Type II interferon induction and passive transfer depress the murine cytochrome P-450 drug metabolism system.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6157362PubMed
6,156,452Mouse fibroblast (type I) and immune (type II) interferons: pronounced differences in affinity for gangliosides and in antiviral and antigrowth effects on mouse leukemia L-1210R cells.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6156452PubMed
6,155,926Enhancement of human natural cell-mediated cytotoxicity by interferon.Br J Cancer1980https://conductscience.org/library/papers/6155926PubMed
3,872,188Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes.Clin Exp Immunol1985https://conductscience.org/library/papers/3872188PubMed
3,119,213Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3119213PubMed
2,936,412Abnormal expansions of granular lymphocytes: reactive lymphocytosis or chronic leukemia? Case report and literature review.Blut1986https://conductscience.org/library/papers/2936412PubMed
2,446,790Regulation of cell growth by interferon.Cancer Metastasis Rev1987https://conductscience.org/library/papers/2446790PubMed

See all 31 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/338162

GET https://conductscience.org/api/papers/v1/338162/cited_by?page=2